Notably, TP53 and PIK3CA emerged as pivotal players, with TP53 being the most recurrently mutated gene in locally advanced HNC [61,62], and PIK3CA ranked as the most frequently mutated oncogene across human cancers [63]. This evidence concerns the gene TP53 and cancer.